Meni-Med

Company Overview

Snapshot

Founded in December 2010 by Yossi De Levy and Dr. David Michaeli, Meni-Med operates with 1–10 employees. The company has secured funding across one round from Microdel. Meni-Med has successfully carried out clinical trials for its device at the Assaf Harofeh Medical Center.

Business overview

Meni-Med is a Health Tech & Life Sciences company focused on developing medical devices for minimally invasive surgical procedures. The company's core product is a disposable and radiolucent spinal retractor designed to reduce paraspinal tissue damage and post-operative pain. This technology aims to provide benefits such as minimal incisions, controlled access to the surgical site, multi-level access in different spinal anatomies, and optimal visibility, serving surgeons, healthcare providers, and hospitals in markets like the United States and Europe.

Company Intelligence Q&A

What is Meni-Med's primary product?

Meni-Med is developing a disposable and radiolucent spinal retractor specifically designed for minimally invasive surgical procedures, aiming to reduce paraspinal tissue damage and post-operative pain.

When was Meni-Med founded and by whom?

Meni-Med was founded in December 2010 by Yossi De Levy and Dr. David Michaeli.

Has Meni-Med conducted clinical trials for its device?

Yes, clinical trials with Meni-Med's device were successfully carried out under Helsinki approval at the Assaf Harofeh Medical Center.

What are the key features of Meni-Med's retractor?

Meni-Med's retractor features micron retraction capability, allowing for minimal incisions, non-traumatic tissue access, multi-level access, illuminated optimal visibility, and radiolucent abilities, all contributing to shorter surgery times and quicker patient recovery.

In which markets does Meni-Med operate?

Meni-Med operates in geomarkets including the United States and Europe, targeting surgeons, healthcare providers, and hospitals.